Thomas J. Schall, President and CEO at ChemoCentryx, Inc. (CCXI), sold 57,544 shares at $65.03 ($3.7M) on 2020-12-14, disclosed to the SEC on 2020-12-16.
Open-market sale of $3.7M CCXI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.03 | 11,153 | $725K | 19.4% |
| 2 | $65.03 | 11,153 | $725K | 19.4% |
| 3 | $65.01 | 17,619 | $1.1M | 30.6% |
| 4 | $65.01 | 17,619 | $1.1M | 30.6% |
| Total | $65.02 avg | 57,544 | $3.7M | 100% |
| Filing → |
| IMRX | BUY | 2025-06-18 | $179K | — | Filing → |
| IMRX | BUY | 2024-03-25 | $7K | — | Filing → |
| CCXI | SELL | 2022-08-08 | $6.5M | — | Filing → |